Showing results (541-550 of 5,984) with videos related to
Sort By:
Pageof 599
Molecular Cancer Therapeutics|July 29, 2016
Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle StudyArthur Winer, Maxwell Janosky, Beth Harrison, et al.Molecular Cancer Therapeutics|July 27, 2016
Vitamin D Enhances the Efficacy of Irinotecan through miR-627-Mediated Inhibition of Intratumoral Drug MetabolismMeiyan Sun, Qunshu Zhang, Xiaoyu Yang, et al.Molecular Cancer Therapeutics|July 27, 2016
Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive CancerIlkka Liikanen, Siri Tähtinen, Kilian Guse, et al.Molecular Cancer Therapeutics|July 27, 2016
Receptor Tyrosine Kinase Phosphorylation Pattern-Based Multidrug Combination Is an Effective Approach for Personalized Cancer TreatmentXiaoxiao Sun, Qiaoling Song, Li He, et al.Molecular Cancer Therapeutics|July 17, 2016
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to CetuximabMari Iida, Harsh Bahrar, Toni M Brand, et al.Molecular Cancer Therapeutics|June 19, 2003
Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpointZehan Chen, Zhan Xiao, Jun Chen, et al.Molecular Cancer Therapeutics|June 19, 2003
ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma modelMitsuhiro Matsuo, Hiroaki Sakurai, Ikuo SaikiMolecular Cancer Therapeutics|June 19, 2003
Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cellsYijiang Shi, Joseph Gera, Jung-Hsin Hsu, et al.Molecular Cancer Therapeutics|March 27, 2003
Inhibition of telomerase activity in human cancer cells by RNA interferenceBarbara A Kosciolek, Kriton Kalantidis, Martin Tabler, et al.Molecular Cancer Therapeutics|March 27, 2003
Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivativeStephen K Tahir, Michael A Nukkala, Nicolette A Zielinski Mozny, et al.Pageof 599